Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.

BACKGROUND--There is uncertainty regarding the use of monotherapy or combination therapy with beta 2 agonists and anticholinergic drugs in patients with chronic obstructive pulmonary disease (COPD). The measurement of forced expiratory volume in one second (FEV1) or relaxed vital capacity (RVC) in t...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Thorax
Principais autores:	Newnham, D. M., Dhillon, D. P., Winter, J. H., Jackson, C. M., Clark, R. A., Lipworth, B. J.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1993
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC464905/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8296260/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.48.11.1151
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!